Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Didier Cataldo, Renaud Louis, Alain Michils, Rudi Peché, Charles Pilette, Florence Schleich, Vincent Ninane & Shane Hanon. (2021) Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways. Journal of Asthma 58:4, pages 448-458.
Read now
Read now
Sola Han, Siin Kim, Hyungtae Kim & Hae Sun Suh. (2019) Cost–utility analysis of reslizumab for patients with severe eosinophilic
asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting
β2-agonists in South Korea. Current Medical Research and Opinion 35:9, pages 1597-1605.
Read now
Read now
Jagdeep Sahota & Douglas S Robinson. (2018) Update on new biologics for intractable eosinophilic asthma: impact of reslizumab. Drug Design, Development and Therapy 12, pages 1173-1181.
Read now
Read now
Mika J. Mäkelä, Helene Nordahl Christensen, Antti Karlsson, Sarang Rastogi & Kirsi Kettunen. (2018) Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland. European Clinical Respiratory Journal 5:1.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi & Mario Cazzola. (2017) Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology 13:9, pages 1007-1013.
Read now
Read now
Mitchell Goldman, Ian Hirsch, James G. Zangrilli, Paul Newbold & Xiao Xu. (2017) The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies. Current Medical Research and Opinion 33:9, pages 1605-1613.
Read now
Read now
Articles from other publishers (30)
Mohammed O Al Ghobain, Abdullah S Alsubaie, Walaa A Aljumah, Fahad M Alrumayh, Khalid F Aldawsari, Asma M Alqahtani & Sultan N Alotaibi. (2023) The Correlation Between Fractional Exhaled Nitric Oxide (FeNO), Blood Eosinophil Count, Immunoglobulin E Levels, and Spirometric Values in Patients With Asthma. Cureus.
Crossref
Crossref
Enrico Maggi, Paola Parronchi, Bruno Giuseppe Azzarone & Lorenzo Moretta. (2022) A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders. Allergy 77:11, pages 3267-3292.
Crossref
Crossref
Paddy McCrossan, Dara O'Donoghue, James Charles McElnay & Michael D. Shields. (2022) The use of remote video directly observed therapy to improve both inhaler technique and adherence to asthma medications. Frontiers in Public Health 10.
Crossref
Crossref
Zoltán Szittner, Beatrix Péter, Sándor Kurunczi, Inna Székács & Robert Horvath. (2022) Functional blood cell analysis by label-free biosensors and single-cell technologies. Advances in Colloid and Interface Science 308, pages 102727.
Crossref
Crossref
Mona Al-Ahmad, Hassan Mobayed, Nasser Al Busaidi, Mohamed Nizam Iqbal, Saif Al Mubaihsi, Moussa Khadadah, Abeer Kassem, Mohamed Abuzakouk, Mateen Uzbeck, Ashraf Al Zaabi & Hisham Farouk. (2022) Severe asthma treatment patterns: A multicenter observational study in the Gulf region. World Allergy Organization Journal 15:5, pages 100647.
Crossref
Crossref
Yu Yang, Lin Yuan, Ming Yang, Xizi Du, Ling Qin, Leyuan Wang, Kai Zhou, Mengping Wu, Ruoxi He, Juntao Feng, Yang Xiang, Xiangping Qu, Huijun Liu, Xiaoqun Qin & Chi Liu. (2021) Aberrant Methylation of Aging-Related Genes in Asthma. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Sandra Elena-Pérez, David Hansoe Heredero-Jung, Asunción García-Sánchez, Miguel Estravís, Maria J. Martin, Jacinto Ramos-González, Juan Carlos Triviño, María Isidoro-García, Catalina Sanz & Ignacio Dávila. (2021) Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma. Frontiers in Medicine 7.
Crossref
Crossref
Marina Bantulà, Jordi Roca-Ferrer, Ebymar Arismendi & César Picado. (2021) Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation. Journal of Clinical Medicine 10:2, pages 169.
Crossref
Crossref
Bruno Sposato, Marco Scalese, Gianna Camiciottoli, Giovanna Elisiana Carpagnano, Corrado Pelaia, Pierachille Santus, Mauro Maniscalco, Angelo Corsico, Amelia Grosso, Stefano Baglioni, Nicola Murgia, Ilenia Folletti, Girolamo Pelaia, Simonetta Masieri, Carlo Cavaliere, Antonino Musarra, Elena Bargagli, Alberto Ricci, Manuela Latorre, Pierluigi Paggiaro & Paola Rogliani. (2021) Mepolizumab Effectiveness and Allergic Status in Real Life. International Archives of Allergy and Immunology 182:4, pages 311-318.
Crossref
Crossref
Glenn Clinton Shedd, Alexandra Thompson & Robert Owen Calvert. (2021) Recognizing asthma in patients with chronic obstructive pulmonary disease. Journal of the American Association of Nurse Practitioners 33:7, pages 537-542.
Crossref
Crossref
Marwan Hassani, Guus Leijte, Niklas Bruse, Matthijs Kox, Peter Pickkers, Nienke Vrisekoop & Leo Koenderman. (2020) Differentiation and activation of eosinophils in the human bone marrow during experimental human endotoxemia. Journal of Leukocyte Biology 108:5, pages 1665-1671.
Crossref
Crossref
Njira L. Lugogo, James L. Kreindler, Ubaldo J. Martin, Bill Cook, Ian Hirsch & Frank J. Trudo. (2020) Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma. Annals of Allergy, Asthma & Immunology 125:2, pages 171-176.
Crossref
Crossref
Guida Giuseppe & Antonelli Andrea. 2020. Cells of the Immune System. Cells of the Immune System.
Juwhan Choi, Jae Kyeom Sim, Jee Youn Oh, Young Seok Lee, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Ji-yong Moon & Kyung Hoon Min. (2020)
Relationship between Particulate Matter (PM
10
) and Airway Inflammation Measured with Exhaled Nitric Oxide Test in Seoul, Korea
. Canadian Respiratory Journal 2020, pages 1-7.
Crossref
Crossref
Min Song, Shan Cai, Hong Luo, Yi Jiang, Min Yang, Yan Zhang, Hong Peng & Ping Chen. (2019) Short-term pulmonary infiltrate with eosinophilia caused by asthma: a phenotype of severe, eosinophilic asthma? Five cases and a review of the literature. Allergy, Asthma & Clinical Immunology 15:1.
Crossref
Crossref
Shoaib Faruqi, Sean Zhou, Joanne Thompson, Terry Robinson, Karen Watkins, Helena Cummings, Nicola Jackson, Anoop Prakash & Michael Crooks. (2019)
Suppression of
F
ENO
with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
. ERJ Open Research 5:4, pages 00123-2019.
Crossref
Crossref
G. Labbé, C. Egron, A. Labbé, B. Pereira & A. Mulliez. (2019) Quelle signification d’une hyperésosinophilie sanguine (plus de 500 giga/L) retrouvée lors du bilan initial d’asthme de l’enfant ?. Revue Française d'Allergologie 59:6, pages 447-453.
Crossref
Crossref
Elisabet Nerpin, Mario Olivieri, Thorainn Gislason, Anna C. Olin, Rune Nielsen, Ane Johannessen, Diogenes S. Ferreira, Alessandro Marcon, Lucia Cazzoletti, Simone Accordini, Isabelle Pin, Angelo Corsico, Pascal Demoly, Joost Weyler, Dennis Nowak, Rain Jõgi, Bertil Forsberg, Jan P. Zock, Torben Sigsgaard, Joachim Heinric, Roberto Bono, Bénédicte Leynaert, Deborah Jarvis, Christer Janson & Anderi Malinovschi. (2019)
Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey
III
. Clinical & Experimental Allergy 49:7, pages 969-979.
Crossref
Crossref
Ravdeep Kaur & Geoffrey Chupp. (2019) Phenotypes and endotypes of adult asthma: Moving toward precision medicine. Journal of Allergy and Clinical Immunology 144:1, pages 1-12.
Crossref
Crossref
Paul Brinkman, Ariane H. Wagener, Pieter-Paul Hekking, Aruna T. Bansal, Anke-Hilse Maitland-van der Zee, Yuanyue Wang, Hans Weda, Hugo H. Knobel, Teunis J. Vink, Nicholas J. Rattray, Arnaldo D'Amico, Giorgio Pennazza, Marco Santonico, Diane Lefaudeux, Bertrand De Meulder, Charles Auffray, Per S. Bakke, Massimo Caruso, Pascal Chanez, Kian F. Chung, Julie Corfield, Sven-Erik Dahlén, Ratko Djukanovic, Thomas Geiser, Ildiko Horvath, Nobert Krug, Jacek Musial, Kai Sun, John H. Riley, Dominic E. Shaw, Thomas Sandström, Ana R. Sousa, Paolo Montuschi, Stephen J. Fowler & Peter J. Sterk. (2019) Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma. Journal of Allergy and Clinical Immunology 143:5, pages 1811-1820.e7.
Crossref
Crossref
Ewa Rakowski, Sibo Zhao, Mengling Liu, Shilpi Ahuja, Nedim Durmus, Gabriele Grunig, Maria Curotto de Lafaille, Yinxiang Wu & Joan Reibman. (2019) Variability of blood eosinophils in patients in a clinic for severe asthma. Clinical & Experimental Allergy 49:2, pages 163-170.
Crossref
Crossref
L. Brussino, E. Heffler, C. Bucca, S. Nicola & G. Rolla. (2018) Eosinophils Target Therapy for Severe Asthma: Critical Points. BioMed Research International 2018, pages 1-6.
Crossref
Crossref
Tara F. Carr & Monica Kraft. (2018) Use of biomarkers to identify phenotypes and endotypes of severe asthma. Annals of Allergy, Asthma & Immunology 121:4, pages 414-420.
Crossref
Crossref
Andrew Menzies-Gow, G-Walter Canonica, Tonya A. Winders, Jaime Correia de Sousa, John W. Upham & Antje-Henriette Fink-Wagner. (2018) A Charter to Improve Patient Care in Severe Asthma. Advances in Therapy 35:10, pages 1485-1496.
Crossref
Crossref
Lucia Calciano, Laura Portas, Angelo Guido Corsico, Mario Olivieri, Paolo Degan, Marcello Ferrari, Alessandro Fois, Anna Maria Fratta Pasini, Andrea Pasini, Maria Elisabetta Zanolin, Roberto de Marco & Simone Accordini. (2018) Biomarkers related to respiratory symptoms and lung function in adults with asthma. Journal of Breath Research 12:2, pages 026012.
Crossref
Crossref
Jeffrey M. Chambliss, Sanjiv Sur & Julia W. Tripple. (2018) Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5. Current Opinion in Allergy & Clinical Immunology 18:1, pages 26-31.
Crossref
Crossref
J Mark FitzGerald, Eugene R Bleecker, Andrew Menzies-Gow, James G Zangrilli, Ian Hirsch, Paul Metcalfe, Paul Newbold & Mitchell Goldman. (2018) Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. The Lancet Respiratory Medicine 6:1, pages 51-64.
Crossref
Crossref
Claudia L. Gaefke & Tara F. Carr. 2018. Personalizing Asthma Management for the Clinician. Personalizing Asthma Management for the Clinician
59
67
.
Sophie F. Demarche, Florence N. Schleich, Virginie A. Paulus, Monique A. Henket, Thierry J. Van Hees & Renaud E. Louis. (2017) Is it possible to claim or refute sputum eosinophils ? 3% in asthmatics with sufficient accuracy using biomarkers?. Respiratory Research 18:1.
Crossref
Crossref
Anne M. Fitzpatrick & Wendy C. Moore. (2017) Severe Asthma Phenotypes — How Should They Guide Evaluation and Treatment?. The Journal of Allergy and Clinical Immunology: In Practice 5:4, pages 901-908.
Crossref
Crossref